Atlantic Canada Oncology Group


ACOG is proud of our speakers.

Bishal Gyawali, MD, PhD is currently an assistant professor in the Department of Public Health Sciences, scientist in the Division of Cancer Care and Epidemiology and a clinical fellow in the Department of Medical Oncology  at Queen’s University, Kingston, Canada and an affiliated faculty at the Program On Regulation, Therapeutics and Law in the Department of Medicine at Brigham and Women’s Hospital, Boston, USA. He also previously served as a medical consultant for the not-for-profit Anticancer Fund, Belgium. He is in the editorial and advisory board for multiple medicine and oncology journals including Journal of Global Oncology, Journal of Oncology Practice and ecancer. He has authored or co-authored more than 80 peer-reviewed articles. His areas of academic interests include cancer policy, global oncology, evidence-based oncology, financial toxicities of cancer treatment, clinical trial methods, and supportive care. He is an advocate of “cancer groundshot“, a term he coined to imply that investment should be made on proven high-value interventions in cancer care that are easy to implement globally and are affordable. He is also the recipient of the 2020 Conquer Cancer Bristol Myers Squibb Global Oncology Young Investiagtor Award in Implementation Science. Dr. Gyawali tweets at @oncology_bg.

Dr. Kylea Potvin is a medical oncologist at the London Regional Cancer Program with expertise in treating breast and Genitourinary cancers. She is an Associate Professor in the Department of Oncology at Western University, and is the Residency Training Program Director in Medical Oncology. Additional roles have included Chair of the Genitourinary Disease Site Team, and the Fellowship Chair for the Canadian Association of Medical Oncology.
Dr. Potvin completed her Medical School at McMaster University, Internal Medicine and Medical Oncology training at Dalhousie University. She is a Harvard Macy Scholar, and has done extensive training in Education and Communication at Harvard University. She has received several awards for education and leadership.
Current academic pursuits include leading faculty development in medical education, coaching and serious illness communication.

Mariò E Lacouture is an Associate Professor and the director of the Oncodermatology Program in the Dermatology Service at Memorial Sloan Kettering Cancer Center in New York City. He did his postdoctoral work at Brigham and Women’s Hospital in Boston, MA, an internship in General Surgery at Cleveland Clinic and residency in dermatology at The University of Chicago, IL. He received his M.D. degree from Javeriana University in Bogota, Colombia, where he grew up. His research interests span the disciplines of dermatologic conditions in cancer patients, and those that arise as a consequence of chemotherapy and/or radiotherapy or stem cell transplants. Dr. Lacouture is currently the Principal Investigator for “The CHANCE Trial”, A Longitudinal Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women with Non-Metastatic Breast Cancer. Dr. Lacouture is a well-known lecturer in the US and abroad on dermatologic conditions as a result of cancer therapies. He founded a clinical program that encompasses patient care, education, and research on dermatologic care in cancer patients and survivors. He is currently Co-Chair of the Skin Toxicity Study Group of the Multinational Association of Supportive Care in Cancer and is on the advisory board of
Cancer.Net and Bridges, the Newsletter for Cancer Survivors. In 2012, CancerCare named Dr
Lacouture as Physician of the Year for his contributions to the education of people living with
cancer. Dr Lacouture has published over 180 articles in peer-reviewed journals and is the author of Dr Lacouture’s Skin Care Guide for People Living With Cancer and Editor of the textbook Dermatologic Principles and Practice in Oncology.

Michael Gardam MSc, MD, CM, MSc, FRCPC, CHE

Michael is Senior Medical Advisor to the CEO of Health PEI on system transformation and engagement.  He is a pioneer of using complexity science-based approaches, including ‘Positive Deviance’ and ‘Front Line Ownership’ to improve patient safety and other complex challenges. Michael has advised organizations in Canada and internationally and some of his clients have included the World Health Organization, the Centers for Disease Control and Prevention, Excellus Blue Cross Blue Shield, Hand Hygiene New Zealand, the Irish Health Services Executive and the Maryland Patient Safety Center, the Canadian Foundation for Healthcare Improvement as well as numerous hospitals across Canada.

His interest in physician leadership and organizational culture led him to become Chair of the Medical Advisory Committee at UHN (2015-2017) and Chief of Staff and Humber River Hospital in Toronto (2018-2020). He currently Program Director of the York University Schulich School of Business Healthcare Leadership Development Program and an instructor for the Physician Leadership Institute of Joule (Canadian Medical Association). Education clients have included the Ontario Medical Association, the Medical Society of Prince Edward Island, Doctors of BC and a Toronto hospital consortium. 

As past Medical Director of Infection Prevention and Control at the University Health Network (2001-2016), past Director of Infectious Disease Prevention and Control at Public Health Ontario (2008 – 2010), and a former Director at Infection Prevention and Control Canada (2009-2015), Michael has worked to prevent the spread of infectious diseases in healthcare settings and the community.

Michael is an Associate Professor of Medicine at the University of Toronto and has published more than 120 scientific works. He holds Masters degrees from McGill University in Montréal and the University of Toronto and is a Fellow of the Royal College of Physicians and Surgeons of Canada in infectious diseases.